Ms Alison Nicole Luberski, CCC-SLP | |
2700 Southaven Rd, Annapolis, MD 21401-7122 | |
(410) 897-1300 | |
Not Available |
Full Name | Ms Alison Nicole Luberski |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 2700 Southaven Rd, Annapolis, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1619395985 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 07143 (Maryland) | Primary |
Provider Name | Functional Independence Therapy Rehabilitation Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1467695759 PECOS PAC ID: 1951451491 Enrollment ID: O20090604000405 |
News Archive
Advanced Cancer Therapeutics (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that it has signed an agreement to leverage the computational chemistry expertise of Dr. John Trent, Associate Professor, Department of Medicine at the University of Louisville's James Graham Brown Cancer Center (Brown Cancer Center), to accelerate the identification of new clinical candidates for the prevention and treatment of cancer.
African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Center.
Movie characters from the Terminator to the Bionic Woman use bionic eyes to zoom in on far-off scenes, have useful facts pop into their field of view, or create virtual crosshairs.
Cephalon, Inc. today announced the journal Cancer has published a pivotal study demonstrating that TREANDA® (bendamustine HCl) for Injection induced durable responses in patients with indolent B-cell non-Hodgkin's lymphoma (NHL) whose disease had progressed during or within six months of treatment with rituximab.
› Verified 6 days ago
Provider Name | At Home By Enhance Therapies Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1124603246 PECOS PAC ID: 4183033210 Enrollment ID: O20210503001929 |
News Archive
Advanced Cancer Therapeutics (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that it has signed an agreement to leverage the computational chemistry expertise of Dr. John Trent, Associate Professor, Department of Medicine at the University of Louisville's James Graham Brown Cancer Center (Brown Cancer Center), to accelerate the identification of new clinical candidates for the prevention and treatment of cancer.
African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Center.
Movie characters from the Terminator to the Bionic Woman use bionic eyes to zoom in on far-off scenes, have useful facts pop into their field of view, or create virtual crosshairs.
Cephalon, Inc. today announced the journal Cancer has published a pivotal study demonstrating that TREANDA® (bendamustine HCl) for Injection induced durable responses in patients with indolent B-cell non-Hodgkin's lymphoma (NHL) whose disease had progressed during or within six months of treatment with rituximab.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Ms Alison Nicole Luberski, CCC-SLP 1841 Light St, Baltimore, MD 21230-4920 Ph: (215) 919-2818 | Ms Alison Nicole Luberski, CCC-SLP 2700 Southaven Rd, Annapolis, MD 21401-7122 Ph: (410) 897-1300 |
News Archive
Advanced Cancer Therapeutics (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that it has signed an agreement to leverage the computational chemistry expertise of Dr. John Trent, Associate Professor, Department of Medicine at the University of Louisville's James Graham Brown Cancer Center (Brown Cancer Center), to accelerate the identification of new clinical candidates for the prevention and treatment of cancer.
African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Center.
Movie characters from the Terminator to the Bionic Woman use bionic eyes to zoom in on far-off scenes, have useful facts pop into their field of view, or create virtual crosshairs.
Cephalon, Inc. today announced the journal Cancer has published a pivotal study demonstrating that TREANDA® (bendamustine HCl) for Injection induced durable responses in patients with indolent B-cell non-Hodgkin's lymphoma (NHL) whose disease had progressed during or within six months of treatment with rituximab.
› Verified 6 days ago
Fran L Silverman, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 | |
Anne Caverly, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 | |
Taylor Falatach, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 Williams Dr, Annapolis, MD 21401 Phone: 609-519-1954 | |
Mrs. Betty Chan-brown, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 190 Admiral Cochrane Dr, Suite 180, Annapolis, MD 21401 Phone: 410-571-6411 Fax: 410-571-6415 | |
Mrs. Judith Ann Wildner, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 | |
Rajavi Sanghavi, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 900 Van Buren St, Annapolis, MD 21403 Phone: 410-267-8653 Fax: 877-828-2060 | |
Victoria Washington-harper, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 |